neostigmine has been researched along with Hypersensitivity, Type III in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A man with ocular myasthenia gravis had rapidly progressing pulmonary hemorrhage, acute renal failure, arthralgias, and palpable purpura." | 1.26 | Immune complex disease with fatal pulmonary hemorrhage: its occurrence in a patient with myasthenia gravis. ( Collins, AB; Dickersin, GR; Kiprov, D; Kradin, L; Kradin, RL; Mark, EJ, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kradin, RL | 1 |
| Kiprov, D | 1 |
| Dickersin, GR | 1 |
| Collins, AB | 1 |
| Kradin, L | 1 |
| Mark, EJ | 1 |
1 other study available for neostigmine and Hypersensitivity, Type III
| Article | Year |
|---|---|
Immune complex disease with fatal pulmonary hemorrhage: its occurrence in a patient with myasthenia gravis.
Topics: Adrenal Cortex Hormones; Choroid Plexus; Eye Diseases; Fluorescent Antibody Technique; Hemorrhage; H | 1981 |